Every record from Janoshik · page 4
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042536 | Tesamorelin | ERP | ERP-2604-W7280 | 2026-Q3 | 98.43 | 4.33 | 107.5 | Supplier-supplied | 2 | FAIL |
| AX-2026-043316 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 96.14 | 5.00 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-043037 | Retatrutide | KP | KP-2607-H5219 | 2026-Q3 | 96.09 | 5.96 | 95.3 | Supplier-supplied | 2 | FAIL |
| AX-2026-043038 | Retatrutide | KP | KP-2607-H5219 | 2026-Q3 | 96.47 | 6.07 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042667 | CJC-1295 (no DAC) | GGPeps | GGPE-2606-E8495 | 2026-Q3 | 98.13 | 4.22 | 106.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042187 | Ipamorelin | Homopeptide | HOMO-2608-A9045 | 2026-Q3 | 99.30 | 4.83 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043091 | Ipamorelin | KP | KP-2606-D5887 | 2026-Q3 | 98.48 | 3.94 | 102.7 | Supplier-supplied | 1 | FAIL |
| AX-2026-042192 | Retatrutide | Homopeptide | HOMO-2605-V9833 | 2026-Q3 | 99.47 | 3.37 | 105.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043418 | Sermorelin | WXT | WXT-2608-P4867 | 2026-Q3 | 98.47 | 2.88 | 89.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043201 | Semaglutide | GL Biochem | GLBI-2602-U8631 | 2026-Q3 | 96.91 | 5.77 | 91.2 | Supplier-supplied | 2 | FAIL |
| AX-2026-043537 | CJC-1295 with DAC | BCH | BCH-2607-H7307 | 2026-Q3 | 98.45 | 5.49 | 103.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042174 | Semaglutide | Homopeptide | HOMO-2604-X8921 | 2026-Q3 | 98.54 | 5.11 | 90.0 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-041931 | Semaglutide | TFC | TFC-2604-X4301 | 2026-Q3 | 99.43 | 4.57 | 106.3 | Supplier-supplied | 0 | PASS |
| AX-2026-041379 | BPC-157 | WWB | WWB-2606-H3906 | 2026-Q3 | 99.72 | 4.51 | 95.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043403 | Semaglutide | WXT | WXT-2604-C4728 | 2026-Q3 | 97.10 | 3.88 | 97.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043103 | Tirzepatide | KP | KP-2608-D5921 | 2026-Q3 | 98.91 | 5.86 | 107.0 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-042472 | Melanotan II | SWB | SWB-2603-A5707 | 2026-Q3 | 99.55 | 4.28 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041726 | CJC-1295 with DAC | QSC | QSC-2602-E9474 | 2026-Q3 | 99.15 | 7.01 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043331 | Liraglutide | CPC | CPC-2602-G1978 | 2026-Q3 | 96.98 | 4.57 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043034 | Retatrutide | KP | KP-2607-H5219 | 2026-Q3 | 96.13 | 5.53 | 90.5 | Supplier-supplied | 2 | FAIL |
| AX-2026-042891 | CJC-1295 (no DAC) | MKM | MKM-2603-V2347 | 2026-Q3 | 99.28 | 3.63 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042475 | Melanotan II | SWB | SWB-2603-A5707 | 2026-Q3 | 99.42 | 4.21 | 105.7 | Supplier-supplied | 0 | PASS |
| AX-2026-043535 | CJC-1295 with DAC | BCH | BCH-2607-H7307 | 2026-Q3 | 97.56 | 5.31 | 107.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042395 | Semaglutide | SWB | SWB-2602-X5278 | 2026-Q3 | 98.69 | 3.57 | 89.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041848 | TB-500 | JEEP | JEEP-2602-V3434 | 2026-Q3 | 99.50 | 3.15 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042546 | Survodutide | ERP | ERP-2605-E7682 | 2026-Q3 | 98.01 | 5.78 | 105.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043419 | Sermorelin | WXT | WXT-2608-P4867 | 2026-Q3 | 98.40 | 3.38 | 106.3 | Supplier-supplied | 0 | PASS |
| AX-2026-043312 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 96.32 | 5.58 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-043179 | Kisspeptin-10 | GL Biochem | GLBI-2608-N8085 | 2026-Q3 | 98.45 | 3.90 | — | Laboratory-retained | 2 | FAIL |
| AX-2026-042289 | GHRP-6 | HJ | HJ-2603-R2258 | 2026-Q3 | 99.53 | 2.67 | 104.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042171 | Semaglutide | Homopeptide | HOMO-2604-X8921 | 2026-Q3 | 99.41 | 4.43 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041732 | CJC-1295 with DAC | QSC | QSC-2602-E9474 | 2026-Q3 | 98.40 | 6.85 | 101.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041325 | Semaglutide | WWB | WWB-2606-N3192 | 2026-Q3 | 99.12 | 4.27 | 105.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043538 | CJC-1295 with DAC | BCH | BCH-2607-H7307 | 2026-Q3 | 97.92 | 5.97 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043107 | Tirzepatide | KP | KP-2608-D5921 | 2026-Q3 | 98.93 | 5.64 | 91.7 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-043334 | Liraglutide | CPC | CPC-2602-G1978 | 2026-Q3 | 97.67 | 4.07 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043326 | Tirzepatide | CPC | CPC-2607-L2552 | 2026-Q3 | 96.89 | 5.16 | 88.5 | Supplier-supplied | 3 | FAIL |
| AX-2026-042647 | Melanotan II | GGPeps | GGPE-2603-P8735 | 2026-Q3 | 99.48 | 7.06 | — | Supplier-supplied | 4 | MARGINAL |
| AX-2026-042212 | LL-37 | Homopeptide | HOMO-2602-G1280 | 2026-Q3 | 99.01 | 5.59 | 105.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041972 | Humanin (HNG) | TFC | TFC-2605-U5564 | 2026-Q3 | 99.48 | 6.11 | 92.0 | Supplier-supplied | 1 | MARGINAL |